Established in 2001 and headquartered in Rowville, Australia, Universal Biosensors, Inc., through its subsidiary Universal Biosensors Pty Ltd, operates as a specialized biosensor technology company. Its core business involves the creation, production, and market introduction of point-of-use devices designed to measure analytes across diverse industries. Within the medical field, the company manufactures and provides Prothrombin Time International Normalized Ratio coagulation test strips, and also acts as a distributor for Siemens' Xprecia Stride Coagulation Analyzer, which is crucial for monitoring individuals undergoing warfarin anticoagulant treatment. For the winemaking sector, UBI produces and distributes Sentia SO2 test strips and supplies the Sentia Analyzer, essential for determining free sulfur dioxide levels in post-fermentation wine. Additionally, the company offers non-diagnostic laboratory services and conducts specific coagulation testing. A key collaboration includes a licensing agreement with LifeScan Global Corporation to develop a biosensor strip and an accompanying meter for detecting and managing diabetes in animals.